Press release: Umeå, September 15, 2021. Production of Lipum's drug candidate SOL-116 for use in clinical trials has according to plan been initiated by the company's partner Abzena.The drug candidate SOL-116 is an antibody and is thus a biological drug. In collaboration with Lipum's partner Abzena in San Diego, the development of a cell line [...]
Press release: Umeå, September 3, 2021. The dose-finding toxicology- and safety studies on Lipum’s candidate drug (SOL-116) have been completed according to plan and the final Clinical Trial Application (CTA)-enabling toxicology study has now started.The non-clinical program for toxicology- and safety studies of Lipum’s candidate drug (SOL-116) is carried out in collaboration with the contract [...]
Press release: Umeå, 27 August, 2021. Lipum AB has published the interim report for period January to June 2021. Below is a brief summary, a complete report (only in Swedish) is available on the company's website (https://lipum.se/finansiella-rapporter/).CEO Einar Pontén comments: “Lipum has reached a stage when we are preparing for clinical trials. Important intermediate goals have [...]
News: Umeå, 25 august, 2021.Lipums CEO Einar Pontén will present Lipum at LSX Nordic Virtual Congress 6-17 September. The LSX Nordic Congress is annual investment and partnering conference for the Nordic life science and healthcare industry. For further information, please contact: Einar Pontén, CEO E-post: einar.ponten@lipum.se Mobil: +46 70 578 34 95 Web: www.lipum.se About [...]
Press release: Umeå, 19 August, 2021. Professor Olle Hernell that is co-founder and board member of Lipum has been honored with the Macy György award 2021 for his research in human milk and lactation.For almost 50 years Professor of Pediatrics Olle Hernell and his group at Umeå University have been studying breast milk and its [...]
News: Umeå, 6 July 2021. Lennart Lundberg is a Professor of Protein Biotechnology with more than 30 years’ experience in the pharmaceutical and biotechnology industries. He is one of the three founders that started Lipum AB (publ) in 2010 and has since been on the board as both Chairman and member.What made you decide to [...]
Press release: Umeå, 19 June 2021. Extra general meeting in Lipum AB (publ), corporate identity number 556813-5999 (the “Company”) was held on 18 June 2021 in Umeå by postal voting, whereby the shareholders, in accordance with the notice, primarily resolved on the following matters.The extra general meeting appointed Åsa Hansdotter and Ingemar Kihlström as new board [...]
News: Umeå, 24 May 2021. On May 26 at 12:00 am Lipum will tell what´s going on in the company and what the future plans look like. Link to the event. Welcome to meet us! For further information, please contact: Einar Pontén, CEO E-post: einar.ponten@lipum.se Mobile: +46 70 5783495 Web: www.lipum.se About Lipum [...]
Press release: Umeå, 18 March 2021. Lipum's final report for the EU's Horizon 2020 framework program has been approved and the company will receive 496,000 EUR as final payment from the program.Horizon 2020, the EU's framework program for research and development, has granted Lipum a total of EUR 2.2 million to develop SOL-116 for treatment [...]
Press release: Umeå, January 26, 2020. Lipum AB has appointed Marina Norberg Chief Financial Officer (CFO).Marina Norberg has extensive experience as an approved auditor at PwC and as authorized accounting consultant within Aspia AB, the management team of which she belonged. Marina Norberg will report to CEO Einar Pontén and be part of Lipum's management [...]